United States of America

Biocon Biologics enters US market with YESINTEK, offering treatment options for Crohn’s disease, ulcerative colitis, plaque…

Generic equivalent of Bumex approved for treating edema in multiple conditions

While not yet proven to be effective against the coronavirus, vaccines are seen by world leaders as the only real way to restart…